Articles tagged with Measles
A recent survey found that 31% of Americans believe RFK Jr. recommends measles vaccination for children, while 29% believe he does not. The public is evenly divided on the issue, with 40% unsure. The survey also found that most adults reject the link between vaccines and autism.
A University of Maryland study predicts that repealing Florida's measles vaccine mandate could spark the largest measles epidemic in the US in nearly 500 years. The study shows that even without mandate removal, Florida's vaccine-induced herd immunity threshold is below the level needed to protect against sustained transmission.
A cost analysis of the 2025 New Mexico measles outbreak found it carried an estimated societal cost of $5.4 million, with vaccination-related activities accounting for about $2.1 million. The findings underscore the importance of maintaining strong vaccination coverage to prevent future outbreaks.
A study found geographic variation in measles-containing vaccine coverage among 7-year-old children in Northern California, highlighting the need for targeted vaccination efforts. The study assesses county-level data, revealing disparities in vaccination rates across different regions.
A new oral antiviral drug candidate, GHP-88310, efficiently blocks both forms of viral spread and shortens the time period infected animals can transmit the virus. The study demonstrates the drug's suitability to augment traditional ring vaccination against measles.
A new study reveals that Republican lawmakers sponsored 86% of antivaccine bills introduced in state legislatures after the COVID-19 pandemic. Meanwhile, Democratic lawmakers supported provaccine bills, highlighting partisan polarization's impact on vaccine access and public health.
A study found that measles-containing vaccines were administered to only 15% of children in this age group between 2015 and 2025. This proportion remained stable over time, but disparities in vaccine uptake existed among minoritized racial and ethnic groups.
A modelling study across 193 countries found armed conflict is associated with a higher measles burden. The study also suggests that conflict has an indirect impact on the spread of measles through its effects on lower socioeconomic development and greater population displacement.
A study of 193 countries finds that armed conflict leads to more measles cases, even a year after fighting ends. Socioeconomic decline is the strongest connection between conflict and measles, as it erodes health foundations and population vulnerability.
A study by Finnish researchers found that MMR vaccines provide sustained protection against measles transmission in Finland, maintaining herd immunity despite high vaccination coverage. The study identified a 'firewall population' of individuals with sufficient immunity to prevent infection and limit viral spread.
Scientists at La Jolla Institute for Immunology have discovered that 'cross-reactive' T cells can recognize multiple species of paramyxovirus, including measles and Nipah viruses. This broad protection is essential in combating emerging diseases with unknown viral strains.
A new oral antiviral drug candidate, GHP-88310, has been identified for the treatment of orthoparamyxovirus diseases such as measles and Croup syndrome. The compound is effective against a broad spectrum of viruses when taken once daily by mouth and has excellent tolerability.
A study by Boston Children's Hospital researchers found that the US missed four out of seven measles elimination status indicators, with most at risk. The latest outbreak has spread continuously for over a year and affected 45 states since January 2025.
A new study examined measles vaccination coverage in a primary care network following a large post-elimination outbreak. The findings show that MMR coverage remained below herd immunity levels, highlighting the fragility of measles elimination.
Three European countries reach 90% HPV vaccination coverage among girls by age 15, marking progress in cervical cancer prevention. HPV vaccination programmes show significant reductions in infections and precancerous lesions, with early administration increasing full protective potential.
The Vanderbilt Center for Antibody Therapeutics has partnered with Saravir Biopharma to develop human monoclonal antibodies against measles. The antibodies, developed by James Crowe Jr., have shown promising preclinical data in neutralizing the virus and preventing infection in animal models.
According to the latest ECDC report, 7,655 measles cases were reported across 30 countries in 2025, with eight fatalities. This represents a significant decrease from 35,000 cases in 2024 but is still almost double the number of cases in 2023.
A cohort study found that most children received their first dose of MMR vaccine on time, but the proportion not receiving it by age 2 has increased. Children who missed early vaccinations were more likely to not receive any MMR vaccine by age 2.
A new survey by the Annenberg Public Policy Center finds a small but significant drop in the proportion of the public that would recommend getting the MMR vaccine, citing concerns over its safety and effectiveness. The survey also shows declines in perceived safety and effectiveness for other vaccines, such as seasonal flu and Covid-19.
Public Health Alerts provide concise, data-driven information on disease outbreaks and urgent health events. The new series, launched by NEJM Evidence and CIDRAP, offers expert-reviewed reports to support public health evidence-based care.
A new approach developed by University of Waterloo researchers uses social media posts to identify early warning signs of increasing vaccine skepticism. This method can detect patterns in data much more effectively than traditional methods, providing a bigger lead time before an outbreak occurs.
Rapid rise in early measles vaccination observed in February 2025, ahead of CDC guidelines. The study suggests clinician and parental concern drove increased vaccination rates.
The Phase 3 study demonstrated the safety and non-inferiority of EuTYPH-C Inj.® Multi-dose compared to a World Health Organization (WHO) prequalified comparator TCV, Typbar TCV®. The vaccine was shown to be well-tolerated across all age groups with no serious adverse events.
The Annenberg Public Policy Center survey finds that most American adults are unclear about the dangers of measles and the value of vaccination. The survey also shows a decline in support for MMR vaccination among parents, from 90% in November 2024 to 82% in August 2025.
A recent study found that 90% of people in BC's Lower Mainland have detectable antibodies against measles, indicating high vaccine coverage and population protection. However, the study also found lower immunity rates among older adults, with only 75% of those aged 20-39 having measurable antibodies.
A Dutch study found that vaccination coverage among children declined faster in households with lower income and those not attending daycare. The study, which analyzed over 2 million children, identified sociodemographic factors contributing to the decline, including parental education and migration background.
A study explores barriers to measles vaccination among female healthcare workers in a London hospital. The findings highlight low knowledge of measles and its complications, as well as concerns about the vaccine's link to autism. The article argues that ensuring healthcare workers are aware of their vaccination status, providing better...
A large-scale study in Ohio found measles vaccination coverage to be below the 93% herd immunity threshold, highlighting the need for sustained public health strategies to maintain elimination. The persistent immunity gaps suggest a need for equity-focused approaches.
A new study models the impact of MMR vaccination strategies on measles outbreaks in Texas, highlighting the critical role of improving immunization rates. The findings suggest that increasing vaccine coverage can significantly reduce the risk of large-scale measles outbreaks.
A recent Annenberg Public Policy Center survey found that 70% of the public supports vaccine requirements for MMR in schools. The percentage increased from 63% in August 2023. The survey also showed that over 7 in 10 U.S. adults support a policy making it mandatory for parents to vaccinate their children against preventable diseases.
A survey of over 1,600 US adults found that most know the negative impacts of smoking and drinking during pregnancy, but uncertainty exists around vaccines and weight gain recommendations. The majority are unsure about recommended vaccines for pregnant individuals, with a notable drop in knowledge since last year.
Researchers at Penn State and WHO develop a method to predict regional measles vaccination coverage even without accurate survey data. The method uses routinely collected data on potential measles cases, resulting in highly correlated predictions with gold-standard DHS data.
Researchers are creating a single-cell atlas to identify potent antibody therapies against measles, mumps, and rubella viruses. The goal is to accelerate antibody discovery and inform vaccine design.
A new poll by Harvard T.H. Chan School of Public Health and the de Beaumont Foundation found that most U.S. adults (79%) support routine childhood vaccine requirements to attend school, including a majority across party lines. The vast majority of parents and adults believe vaccines are safe for most children.
Pregnant individuals are at high risk of measles infection and its complications. Experts emphasize the need for urgent access to IVIG and updated hospital protocols to protect vulnerable groups.
A nationwide decline in MMR vaccination rates among US children was confirmed by a new dataset, with significant variations observed across states and counties. The study provides valuable insights into factors influencing low vaccination rates and can inform targeted strategies to reduce measles outbreaks.
A new study finds that bats are a reservoir for morbilliviruses, including the human measles virus, and can transmit them to other mammalian species, such as monkeys. The research suggests that these viruses have crossed species boundaries multiple times, posing a significant threat to human health and livestock.
A recent survey found that over 83% of Americans believe the benefits of the MMR vaccine for children outweigh the risks, despite a current measles outbreak. The survey also showed that vaccination rates are dropping and many people lack knowledge about measles symptoms and prevention.
The European Centre for Disease Prevention and Control (ECDC) emphasizes the need for high immunization coverage to protect European populations from diseases like measles and polio. Vaccination remains a crucial tool in public health, with recent data showing a tenfold surge in reported measles cases in the EU/EEA.
Research reveals inequalities in MMR vaccination that may contribute to measles outbreaks and epidemics. In France, vaccines were dispensed later for children from low-income families, while a UK investigation found that deprived communities and some ethnic groups were more affected by the outbreak and less likely to be vaccinated.
A modeling study predicts declining childhood vaccination rates will increase outbreaks of vaccine-preventable infections, leading to their reemergence. Measles is likely to be the first disease to return to endemic levels, even under current vaccination levels.
A recent study by Stanford Medicine researchers warns that measles and other diseases may make a comeback in the US if immunization rates drop. The study found that even at current levels, measles may become endemic within two decades, leading to an estimated 851,300 cases over 25 years.
Researchers trained a machine learning algorithm to identify over 30 viable treatments for diseases caused by bat-borne Nipah and Hendra henipaviruses. The study used Rhodium software to virtually screen compounds based on the protein structure of the measles virus.
Measles vaccination is deemed essential for preventing serious complications, including hospitalization and death. The risk of complications is particularly high in children under 5 years old and those under 1 year old, highlighting the importance of timely vaccination.
The University of Texas at Arlington expert discusses the state's largest outbreak in 30 years, with fewer people getting vaccinated contributing to its spread. The MMR vaccine is 97% effective against measles and has been proven safe despite misconceptions about its safety.
Researchers at Lancaster University discovered a new type of vaccine-specific scepticism, where some people perceive COVID-19 vaccines as 'not a vaccine' compared to MMR. This phenomenon may also apply to the flu vaccine, highlighting the need for clear public health messaging.
The European Centre for Disease Prevention and Control reports a significant increase in measles cases across EU/EEA countries, with eight out of ten unvaccinated individuals contracting the disease. Vaccination levels fall short of the 95% target, leaving vulnerable populations susceptible to measles.
A new survey finds that nearly three-quarters of US adults support requiring children to be vaccinated against preventable diseases, while over half support prohibiting unvaccinated children from attending school. However, support for this prohibition has dropped significantly since the Covid-19 pandemic, and there is growing support f...
Researchers from McGill University and colleagues found that stunted children had lower levels of antibodies against measles by age five. The study suggests that combatting child hunger could help prevent measles outbreaks globally, as undernutrition may affect vaccine protection.
The authors emphasize the importance of increasing vaccination rates to combat decreasing rates globally. They also highlight emerging challenges such as a highly virulent strain of influenza and measles outbreaks, particularly in areas with low vaccination rates.
A modelling study suggests that slow waning of MMR vaccine-induced immunity may contribute to rising measles cases in double-vaccinated people. However, the MMR vaccine remains the most effective measure to prevent measles infection, and community vaccination levels above 95% are essential to prevent outbreaks.
Researchers identified six priority pathogens for WWS during the Paris 2024 Games, including poliovirus, influenza A virus, and SARS-CoV-2. The study offers a model framework for context-specific WWS targets in mass gatherings.
Researchers have discovered how a neutralizing antibody blocks measles virus infection by arresting the fusion process. The study's findings may also be relevant to other viruses with pandemic potential, such as Nipah and parainfluenza viruses.
A multinational research team has identified a novel way to attack measles by targeting specific proteins on the virus, paving the way for new vaccines and antiviral drugs. The study found that antibodies against the fusion protein successfully prevented the virus from completing its merger with the cell membrane.
A study by the University of Cambridge and Fudan University found that children born by C-section are up to 2.6 times more likely to fail their first measles vaccination compared to those born naturally. Two doses of the vaccine are necessary for robust protection against measles.
A phase 1/2 trial found microarray patches to be safe and induce strong immune responses in children, with over 90% protected from measles. The method could help achieve high population immunity levels required to control childhood diseases.
The global measles case total for 2023 is almost double that of the previous year, with a significant increase in cases reported in low- and lower-middle-income countries. Experts attribute this to increased transmission due to gaps in immunization coverage and lack of uniformity in vaccination rates.
Measles is a highly contagious respiratory infectious disease that can cause complications such as ear infections, pneumonia, and neurologic disorders. The measles vaccine is effective and safe, but individuals with immunocompromised conditions require careful consideration.
Researchers found that ferrets infected with influenza or respiratory syncytial virus were more susceptible to lethal pneumonia when later infected with a measles-like virus. Experimental treatment with GHP-88309 prevented this outcome, suggesting a potential therapeutic option.
A study published in EuroSurveillance found that 40% of COVID-19 infected individuals were identified through contact tracing, with socio-economic factors influencing reporting rates. The effectiveness of contact tracing alone was relative, but its psychological impact on the population should not be overlooked.